Epigenetic Age as a Marker of Reproductive Age and Modifier of Invasive Breast Cancer Risk Among Postmenopausal Women
表观遗传年龄作为绝经后妇女生育年龄的标志和侵袭性乳腺癌风险的调节因素
基本信息
- 批准号:9976475
- 负责人:
- 金额:$ 14.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAgeAge at First Live BirthAge at MenarcheAgingAlcoholic beverage heavy drinkerBilateral oophorectomyBioavailableBiologicalBiological AgingBiologyBloodBreast Cancer PreventionBreast Cancer Risk FactorBreast FeedingCancer ControlCell physiologyCellsChronologyClinicalClinical TrialsColorContraceptive UsageDNA MethylationDevelopment PlansDiseaseEndometrial CarcinomaEnvironmental ExposureEnvironmental ImpactEpidemiologistEpigenetic ProcessEstradiolEuropeanFamily history ofFirst BirthsGene Expression RegulationGoalsHealthHealthcareHormonalHormonesIncidenceInterdisciplinary StudyInvestigationKnowledgeLife Cycle StagesLife StyleMalignant NeoplasmsMalignant neoplasm of ovaryMeasurementMeasuresMediatingMenarcheMenopauseMentorshipMethodologyModificationObesityObservational StudyOral ContraceptivesPatternPostdoctoral FellowPostmenopausePremature MenopausePrevention strategyProcessPubertyPublicationsReportingReproductive HistoryReproductive ProcessResearchResearch InstituteResearch PersonnelResearch Project GrantsRiskRisk FactorsScientistSmokerSubgroupTestosteroneTimeTranslatingVariantWhole BloodWomanWomen&aposs HealthWorkbehavior influencecancer biomarkerscancer invasivenesscancer preventioncancer riskcareerclinically relevantcohortdeviantdisorder preventionexperiencegenome-widehazardhigh riskhormone therapyimprovedin uteroinnovationinsightlifestyle factorsmalignant breast neoplasmmortalityparityreproductivereproductive senescencerisk prediction model
项目摘要
Dr. Binder's goal is to become a leading academic epidemiologist in the epigenetic programming of health and
disease, with an emphasis on hormonally responsive cancer risk. She plans to apply innovative methodological
approaches to efficiently capture biologically meaningful changes in gene regulation. Dr. Binder will collaborate
with a broad spectrum of scientists to translate insight from these mechanistic studies into improvements in
health care and disease prevention. Her research thus far has focused on determinants of epigenetic patterns
established in utero and during puberty. The proposed research project will bridge this experience to study the
impact of epigenetic modifications acquired across the life course on postmenopausal breast cancer incidence.
Epigenetic age is a predictor of health and an indicator of biological aging, capturing the cumulative impact of
environmental and behavioral influences across time on cellular function. Prior studies have suggested a positive
correlation between epigenetic aging and cancer risk. Paradoxically, aspects of reproductive history suggested
to decelerate epigenetic age are associated with increased breast cancer incidence. Therefore we hypothesize
there is a clinically relevant interaction between epigenetic age and the process of reproductive aging on
hormonally responsive cancer risk among postmenopausal women. We propose analyzing epigenetic age
acceleration (AgeAccel; deviance between chronological and epigenetic age) within 5,406 postmenopausal
women from the Women's Health Initiative Observational Study and Clinical Trial with previously measured
genome-wide DNA methylation in whole blood. This will include a subset of 1,382 women with bioavailable
estradiol measurements, and 285 cases of invasive breast cancer. We plan to (1) characterize the variation in
AgeAccel associated with reproductive history, (2) assess how AgeAccel is influenced by lifestyle factors, (3)
analyze the association between AgeAccel and bioavailable estradiol and testosterone, (4) investigate how these
hormones may mediate and interact with modifiable and unmodifiable predictors of cancer risk to impact
AgeAccel, and (5) estimate the association between AgeAccel and breast cancer hazard. Together these aims
will separate the influences on biological aging from chronological age relevant for cancers associated with
reproductive history among postmenopausal women. Additionally, this work will appraise the utility of AgeAccel
to track the change in risk profile over time. To conduct this research, Dr. Binder will build her substantive
knowledge of aging and postmenopausal health through organized mentorships, didactic coursework, affiliations
with interdisciplinary research institutes and associated seminars. Furthermore, Dr. Binder will generate new
research partnerships with experts in cancer control and prevention to inform her analytic approach and
interpretations. This development plan will build Dr. Binder's reputation in the epigenetic programming of
women's health and cancer risk through publications and presentations, increase her network of collaborators,
and fuel the submission of a research grant to further her career as an independent investigator in this field.
宾德博士的目标是成为一个领先的学术流行病学家在表观遗传规划的健康和
疾病,重点是癌症风险。她计划采用创新的方法
有效捕获基因调控中有生物学意义的变化的方法。宾德博士将与
广泛的科学家将这些机制研究的见解转化为改进,
卫生保健和疾病预防。到目前为止,她的研究主要集中在表观遗传模式的决定因素上
在子宫内和青春期建立。拟议的研究项目将把这方面的经验结合起来,
表观遗传修饰对绝经后乳腺癌发病率的影响。
表观遗传年龄是健康的预测因子,也是生物衰老的指标,它反映了以下因素的累积影响:
环境和行为对细胞功能的影响。先前的研究表明,
表观遗传衰老和癌症风险之间的相关性。巧合的是,生殖史表明
表观遗传年龄的降低与乳腺癌发病率的增加有关。因此我们假设
表观遗传年龄和生殖衰老过程之间存在临床相关的相互作用,
绝经后妇女的乳腺癌风险。我们建议分析表观年龄
在5,406名绝经后妇女中,
来自妇女健康倡议观察性研究和临床试验的妇女,
全基因组DNA甲基化。这将包括一个由1,382名妇女组成的子集,
雌二醇测量和285例浸润性乳腺癌。我们计划(1)描述
与生殖史相关的生育加速,(2)评估生活方式因素如何影响生育加速,(3)
分析β-Accel与生物可利用的雌二醇和睾酮之间的关系,(4)研究这些因素如何影响生物可利用的雌二醇和睾酮的水平。
激素可能介导并与癌症风险的可改变和不可改变的预测因子相互作用,
评估乳腺癌风险与乳腺癌风险之间的关系。这些目标一起
将把对生物衰老的影响与与癌症相关的实足年龄分开,
绝经后妇女的生育史。此外,这项工作将评估的实用性,
跟踪风险状况随时间的变化。为了进行这项研究,宾德博士将建立她的实质性的
通过有组织的指导,教学课程,附属机构,
与跨学科研究机构和相关研讨会。此外,宾德博士将产生新的
与癌症控制和预防专家建立研究伙伴关系,为她的分析方法提供信息,
解释。这项开发计划将建立宾德博士在表观遗传编程方面的声誉,
妇女的健康和癌症的风险,通过出版物和介绍,增加她的合作者网络,
并推动提交研究补助金,以促进她作为该领域独立调查员的职业生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexandra Margaret Lynn Binder其他文献
Alexandra Margaret Lynn Binder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexandra Margaret Lynn Binder', 18)}}的其他基金
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment
与乳腺癌及其治疗相关的加速生物衰老和功能衰退的长期轨迹
- 批准号:
10729432 - 财政年份:2023
- 资助金额:
$ 14.57万 - 项目类别:
Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification by Resistance Training Intervention
根据表观遗传年龄表征化疗副作用的风险并通过抗阻训练干预进行修改
- 批准号:
10684747 - 财政年份:2021
- 资助金额:
$ 14.57万 - 项目类别:
Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification by Resistance Training Intervention
根据表观遗传年龄表征化疗副作用的风险并通过抗阻训练干预进行修改
- 批准号:
10280002 - 财政年份:2021
- 资助金额:
$ 14.57万 - 项目类别:
Epigenetic Programming of Cardimetabolic Health during Childhood
儿童期心脏代谢健康的表观遗传编程
- 批准号:
10375181 - 财政年份:2020
- 资助金额:
$ 14.57万 - 项目类别:
Epigenetic Age as a Marker of Reproductive Age and Modifier of Invasive Breast Cancer Risk Among Postmenopausal Women
表观遗传年龄作为绝经后妇女生育年龄的标志和侵袭性乳腺癌风险的调节因素
- 批准号:
9754021 - 财政年份:2018
- 资助金额:
$ 14.57万 - 项目类别:
Epigenetic Programming of Cardimetabolic Health during Childhood
儿童期心脏代谢健康的表观遗传编程
- 批准号:
10378461 - 财政年份:2017
- 资助金额:
$ 14.57万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 14.57万 - 项目类别:
Directed Grant














{{item.name}}会员




